RxSight, Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
RxSight, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
  • RxSight, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.33M, a 38.8% increase year-over-year.
  • RxSight, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$42.4M, a 26.5% increase year-over-year.
  • RxSight, Inc. annual Operating Income (Loss) for 2023 was -$50.1M, a 20.9% increase from 2022.
  • RxSight, Inc. annual Operating Income (Loss) for 2022 was -$63.3M, a 20% decline from 2021.
  • RxSight, Inc. annual Operating Income (Loss) for 2021 was -$52.8M, a 49.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$42.4M -$8.33M +$5.29M +38.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$47.7M -$10.7M +$2.43M +18.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$50.1M -$10.9M +$4.14M +27.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$54.2M -$12.5M +$3.45M +21.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$57.7M -$13.6M +$2.17M +13.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$59.8M -$13.1M +$3.48M +21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$63.3M -$15M -$327K -2.23% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$63M -$16M -$2.85M -21.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$60.1M -$15.8M -$1.92M -13.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$58.2M -$16.6M -$5.44M -48.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$52.8M -$14.7M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$13.1M -$4.21M -47.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$13.9M -$5.07M -57.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$11.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 -$8.91M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$8.81M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.